Description
SARS-CoV-2 (COVID-19) NSP8 Protein, His Tag | NS8-C5149-1mg| Gentaur Distribution US, UK & Europe
NSP8, forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers. To ultimately combat the emerging COVID-19 pandemic, it is desired to develop an effective and safe vaccine against this highly contagious disease caused by the SARS-CoV-2 coronavirus. By investigating the entire proteome of SARS-CoV-2, six proteins, including the S protein and five non-structural proteins (nsp3, 3CL-pro, and nsp8-10) were predicted to be adhesins, which are crucial to the viral adhering and host invasion. The S, nsp3, and nsp8 proteins were also predicted by Vaxign-ML to induce high protective antigenicity.
Source: SARS-CoV-2 NSP8, His Tag (NS8-C5149) is expressed from E. coli cells. It contains AA Ala 1 - Gln 198 (Accession # YP_009725304.1).
Format: Liquid.
Tag: N-10×His.
Expression System: E. coli.
Expression Region: Ala 1 - Gln 198.
Conjugate: Unconjugated.
Molecular Weight: 23.9 kDa.
Characteristics: This protein carries a polyhistidine tag at the N-terminus. The protein has a calculated MW of 23.9 kDa. The protein migrates as 22-25 kDa under reducing (R) condition (SDS-PAGE).
Purity: 95%.
Buffer: 20 mM Tris, 250 mM NaCl, pH8.5.
Storage Conditions: -70℃.
Shipping Conditions: Dry ice
